scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1006140775 |
P356 | DOI | 10.1038/SJ.GT.3300543 |
P698 | PubMed publication ID | 9472552 |
P5875 | ResearchGate publication ID | 13757449 |
P2093 | author name string | Rahman A | |
Dritschilo A | |||
Kasid U | |||
Soldatenkov V | |||
Gokhale PC | |||
Wang FH | |||
P433 | issue | 12 | |
P921 | main subject | gene therapy | Q213901 |
P304 | page(s) | 1289-1299 | |
P577 | publication date | 1997-12-01 | |
P1433 | published in | Gene Therapy | Q15763095 |
P1476 | title | Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer | |
P478 | volume | 4 |
Q39471953 | Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism. |
Q37321859 | Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics. |
Q33738466 | Antisense oligonucleotides as therapeutic agents |
Q33607807 | Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides |
Q35153742 | Antisense therapeutics: from theory to clinical practice |
Q36179648 | Clinical trials of a new class of therapeutic agents: antisense oligonucleotides. |
Q28244352 | Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems |
Q27024646 | Delivery of oligonucleotides with lipid nanoparticles |
Q38289833 | Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1. |
Q41630941 | Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures |
Q35185012 | Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft |
Q62602314 | Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line |
Q47408693 | High efficiency entrapment of antisense oligonucleotides in liposomes |
Q73266700 | In vitro transport and delivery of antisense oligonucleotides |
Q47596814 | Lipid-based formulations of antisense oligonucleotides for systemic delivery applications |
Q33723073 | Lipoplexes and tumours. A review |
Q47408658 | Mass spectrometry and enzyme-linked immunosorbent assay methods for the quantitation of liposomal antisense oligonucleotide (LE-rafAON) in human plasma |
Q35208827 | RAF antisense oligonucleotide as a tumor radiosensitizer |
Q38612684 | Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced ce |
Q36200146 | Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity |
Q40321425 | Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression |
Q42803620 | Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide |
Q40705210 | Targeted oligonucleotide delivery in human lymphoma cell lines using a polyethyleneimine based immunopolyplex |
Q36804407 | Targeting the PI3K and MAPK pathways to treat Kaposi's-sarcoma-associated herpes virus infection and pathogenesis |
Q34241295 | The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors |
Q38363836 | The sensitivity of MCF10A breast epithelial cells to alkylating drugs is enhanced by the inhibition of O6-methylguanine-DNA methyltransferase transcription with a synthetic double strand DNA oligonucleotide. |
Q35116151 | Vascular complications and gene therapy |
Search more.